The potential role of excessive PI3K signaling in the development of B-cell malignancies was initially reported by Borlado et al. (2000), who showed that mice expressing a constitutively active form of PI3K develop infiltrating lymphoproliferative disorders as well as autoimmune disease. This evidence concerns the gene PIK3CD and autoimmune disease.